KROS
NASDAQ · Biotechnology

Keros Therapeutics Inc

$10.07
-0.15 (-1.47%)
As of Aug 8, 1:52 AM ET ·
Next Earnings Report
Aug 12, 2026
Before Market Open
3 days away
EPS Estimate $-1.37
Revenue Est $823.3K
EPS Surprise History
Earnings Summary
Beats (Last 2) 0/2
Avg Surprise -25.0%
Latest EPS $-1.21
History 2 quarters
Earnings History
Date Quarter EPS Est EPS Actual Surprise Surprise % Result
May 14, 2026 Q2 FY2026 $-1.04 $-1.21 -$0.17 -16.0% Miss
Apr 30, 2026 Q2 FY2026 $-1.09
Mar 4, 2026 Q1 FY2026 $-0.64 $-0.86 -$0.22 -34.1% Miss
Mar 2, 2026 Q1 FY2026 $-0.64